ABCG2 携带流体杀菌剂 尼托克西尼尔,并影响其生物分布和分泌到牛奶中的情况
Laura Álvarez-Fernández1, Esther Blanco-Paniagua1, Gracia Merino1
1Department of Biomedical Sciences-Physiology, Faculty of Veterinary Medicine, Animal Health Institute (INDEGSAL), University of León, Campus de Vegazana s/n, 24071 León, Spain.
Pharmaceutics
|April 27, 2024
概括
结合ATP的磁带子家族G成员2 (ABCG2) 输送器会影响氧尼尔.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 生物化学 生物化学
背景情况:
- 在药物处置和排毒过程中,ABCG2转运器至关重要.
- 在ABCG2中,异生菌能通过生物障碍物进行活跃的运输.
- 哺乳期表达ABCG2有助于化学物质转移到牛奶中.
研究的目的:
- 调查ABCG2在氧尼尔全身暴露和乳液分泌中的作用.
- 为了确定氧尼尔是否是ABCG2基质.
- 评估ABCG2对体内氧尼尔生物分布的影响.
主要方法:
- 在体外测试中使用过度表达ABCG2.2的MDCK-II细胞.
- 在野生类型和ABCG2淘汰赛小鼠的体内研究.
- 在血,组织和牛奶中量化尼트로キシ尼尔.
主要成果:
- 尼트로西尼尔是跨物种ABCG2的体外基质.
- 鼠类Abcg2显著影响了血中氧尼尔水平.
- Abcg2 缺乏导致脏,肠道和丸中氧的积累发生变化.
- Abcg2 影响尼托克西尼尔分泌到牛奶中,野生类型小鼠的水平更高.
结论:
- 在ABCG2中,ABCG2积极运输氧.
- ABCG2 显著影响氧尼尔的生物分布和牛奶的转移.
- 准ABCG2可能会调节氧尼尔暴露和转移.
相关概念视频
Hepatic Drug Clearance: Role of Transporters
54
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
54
Drug Excretion: Pulmonary and Glandular Routes
108
Gaseous substances like general anesthetics are absorbed and excreted through the lungs via simple diffusion. This process depends on factors such as pulmonary blood flow, respiration rate, and the substance's solubility. Gaseous anesthetics like nitrous oxide with low blood solubility are excreted rapidly, while compounds like alcohol, with high blood and tissue solubility, are excreted slowly.
Drugs can also be excreted in breast milk, which is crucial for breastfeeding infants. The...
Drugs can also be excreted in breast milk, which is crucial for breastfeeding infants. The...
108
Carrier-Mediated Transport
415
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
415
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Nonlinear Pharmacokinetics: Role of Transporters
48
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
48
Drug Distribution: Plasma Protein Binding
5.5K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.5K


